Home » Healthcare » UK Addiction Treatment Market

UK Addiction Treatment Market

UK Addiction Treatment Market By Treatment Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, Other Substances Addiction Treatment); By Drug Type (Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others); By Treatment Center (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers); By Distribution Channel (Hospitals Pharmacies, Medical Stores, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
UK Addiction Treatment Market Size 2023	USD 433.69 million
UK Addiction Treatment Market, CAGR	6.48%
UJK Addiction Treatment Market Size 2032	USD 774.40 million

Market Overview

The UK Addiction Treatment Market is projected to grow from USD 433.69 million in 2023 to an estimated USD 774.40 million by 2032, with a compound annual growth rate (CAGR) of 6.48% from 2024 to 2032. This growth is driven by the increasing prevalence of substance abuse disorders and a heightened awareness of the importance of mental health.

Key drivers of the UK Addiction Treatment Market include the rising incidence of addiction cases, government initiatives to combat substance abuse, and advancements in treatment methodologies. Trends such as the integration of digital health technologies and personalized treatment plans are also contributing to market expansion. These factors are collectively enhancing the accessibility and effectiveness of addiction treatment services across the country.

Geographically, the UK Addiction Treatment Market is dominated by major regions such as London, the Midlands, and the North West. These regions have a higher concentration of treatment facilities and healthcare infrastructure, driving market growth. Key players in the market include The Priory Group, Turning Point, and Forward Trust, who are leading providers of addiction treatment services and are continuously innovating to address the evolving needs of patients. These companies are pivotal in shaping the market dynamics through their extensive service offerings and strategic initiatives.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Drivers

Increasing Prevalence of Substance Abuse Disorders:

The growing incidence of substance abuse disorders significantly drives the UK Addiction Treatment Market. Over recent years, there has been a noticeable rise in the number of individuals grappling with various forms of addiction, including alcohol, opioids, and other recreational drugs. According to the Office for National Statistics (ONS), the number of drug-related deaths in England and Wales reached a record high in recent years, reflecting the urgent need for effective treatment solutions. This escalation can be attributed to several factors, including socioeconomic pressures, mental health issues, and the accessibility of illicit substances. The increasing prevalence of addiction not only places a substantial burden on the healthcare system but also underscores the necessity for specialized treatment services. Healthcare providers and policymakers are responding to this challenge by expanding the availability of treatment facilities and investing in comprehensive care programs. For instance, there were 290,635 adults in contact with drug and alcohol services between April 2022 and March 2023. This rise in demand for addiction treatment services propels market growth as more individuals seek professional help to overcome their dependencies, leading to a higher utilization of various treatment modalities such as inpatient and outpatient programs, counseling, and medication-assisted therapies.

Government Initiatives and Funding:

Government initiatives and funding are pivotal in driving the UK Addiction Treatment Market. Recognizing the critical impact of substance abuse on public health and safety, the UK government has implemented several policies and funding programs aimed at reducing addiction rates and improving treatment accessibility. For example, local authorities across England will benefit from an extra £421 million government funding through to 2025 to improve drug and alcohol addiction treatment and recovery. The National Health Service (NHS) has been at the forefront of these efforts, launching initiatives such as the NHS Long Term Plan, which prioritizes mental health services, including addiction treatment. Additionally, Public Health England (PHE) has undertaken numerous campaigns to raise awareness about the dangers of drug and alcohol abuse and to promote the availability of treatment services. Financial support from the government enables the expansion and enhancement of treatment facilities, ensuring that more individuals can access the help they need. For example, funding has been allocated to increase the number of rehabilitation centers and to support community-based addiction treatment programs. These government actions not only increase the availability of treatment options but also improve the quality of care provided, driving market growth as more people are encouraged to seek treatment.

Advancements in Treatment Methodologies:

Advancements in treatment methodologies are another critical driver of the UK Addiction Treatment Market. The field of addiction treatment has evolved significantly, with new and innovative approaches being developed to enhance the effectiveness of interventions. Research and development in this area have led to the introduction of evidence-based therapies, such as cognitive-behavioral therapy (CBT), motivational interviewing, and contingency management, which have proven to be highly effective in treating various forms of addiction. Additionally, the advent of medication-assisted treatment (MAT) has revolutionized the management of substance use disorders. For instance, the advent of medication-assisted treatment (MAT) has revolutionized the management of substance use disorders. Medications such as methadone, buprenorphine, and naltrexone are now commonly used in combination with behavioral therapies to provide a more holistic approach to addiction treatment. These advancements have improved patient outcomes, reduced relapse rates, and increased the overall success of addiction treatment programs. Furthermore, the integration of digital health technologies, such as telemedicine and mobile health apps, has expanded the reach of addiction treatment services, making it easier for individuals to access care, especially in remote or underserved areas. These technological advancements enhance patient engagement and support continuous monitoring, contributing to the market’s growth by making treatment more accessible and effective.

Growing Awareness and Acceptance of Mental Health Issues:

The growing awareness and acceptance of mental health issues are significantly contributing to the expansion of the UK Addiction Treatment Market. In recent years, there has been a marked shift in societal attitudes towards mental health, with a greater emphasis on the importance of addressing mental health disorders, including addiction. Public awareness campaigns, led by both governmental and non-governmental organizations, have played a crucial role in destigmatizing addiction and encouraging individuals to seek help. High-profile endorsements and media coverage have further highlighted the importance of mental health care, promoting a more open and supportive environment for those affected by addiction. This increased awareness has led to a higher demand for addiction treatment services as more individuals recognize the need for professional help in managing their dependencies. Additionally, the acceptance of addiction as a medical condition rather than a moral failing has fostered a more compassionate approach to treatment, encouraging individuals to seek assistance without fear of judgment. This societal shift has also influenced policy changes, leading to improved funding and support for addiction treatment programs, thereby driving market growth.

Market Trends

Integration of Digital Health Technologies:

One of the most significant trends in the UK Addiction Treatment Market is the integration of digital health technologies. For instance,a company in the UK, has developed an all-digital addiction recovery programme that combines cognitive behavioural therapy with counselling, medical oversight and case management. The adoption of telemedicine, mobile health applications, and online therapy platforms has revolutionized the way addiction treatment services are delivered. These technologies provide patients with greater flexibility and accessibility, allowing them to receive care from the comfort of their homes, which is particularly beneficial for those in remote or underserved areas. Telemedicine platforms enable real-time consultations with healthcare providers, ensuring continuous support and monitoring. Mobile health apps offer a range of services, including self-assessment tools, progress tracking, and access to educational resources, which empower individuals to take an active role in their recovery journey. Additionally, online therapy sessions have become increasingly popular, providing a convenient and confidential way for patients to receive counseling and behavioral therapy. This trend not only enhances patient engagement and adherence to treatment plans but also reduces the stigma associated with seeking help for addiction. The integration of digital health technologies is transforming the addiction treatment landscape, making it more patient-centered and accessible, thereby driving market growth.

Personalized and Holistic Treatment Approaches:

Another emerging trend in the UK Addiction Treatment Market is the shift towards personalized and holistic treatment approaches. Recognizing that addiction is a complex and multifaceted condition, healthcare providers are increasingly adopting individualized treatment plans tailored to the unique needs of each patient. This approach involves a comprehensive assessment of the patient’s medical history, psychological state, and social circumstances to develop a treatment plan that addresses all aspects of their addiction. Personalized treatment plans may include a combination of medication-assisted treatment (MAT), cognitive-behavioral therapy (CBT), motivational interviewing, and other evidence-based therapies. Additionally, there is a growing emphasis on holistic care that integrates physical, mental, and emotional health. This includes incorporating complementary therapies such as mindfulness, yoga, and nutritional counseling into traditional addiction treatment programs. Holistic approaches aim to treat the whole person rather than just the symptoms of addiction, promoting overall well-being and long-term recovery. The trend towards personalized and holistic treatment approaches is driven by the recognition that one-size-fits-all solutions are often ineffective in addressing the diverse needs of individuals struggling with addiction. By providing tailored and comprehensive care, these approaches improve treatment outcomes and enhance the overall effectiveness of addiction treatment programs, contributing to the growth of the market.

Market Restraints and Challenges

Limited Funding and Resource Allocation:

One of the primary restraints in the UK Addiction Treatment Market is the limited funding and resource allocation. Despite the growing need for addiction treatment services, financial resources allocated by the government and private sector often fall short. This underfunding impacts the quality and availability of services, leading to longer waiting times for treatment, insufficient staffing, and inadequate infrastructure in many treatment facilities. The National Health Service (NHS) and other public health organizations face significant budget constraints, which restrict their ability to expand services or invest in new treatment technologies and methodologies. Additionally, many non-governmental organizations and private clinics struggle to secure consistent funding, making it challenging to sustain operations and maintain high standards of care. This financial shortfall not only hampers the capacity to meet the rising demand for addiction treatment but also affects the continuity and comprehensiveness of care provided to patients. Without adequate funding, the ability to implement and maintain innovative treatment programs is severely limited, stifling the overall growth of the market.

Stigma and Societal Perception:

Stigma and societal perception remain significant challenges in the UK Addiction Treatment Market. Despite increasing awareness about addiction as a medical condition, many individuals still face judgment and discrimination, which discourages them from seeking help. This stigma is deeply ingrained in society and can be perpetuated by misconceptions about addiction and those affected by it. Patients often fear being labeled or ostracized, which can lead to delayed treatment or avoidance of professional help altogether. This societal stigma extends to the healthcare system, where individuals with addiction issues may encounter bias or lack of understanding from medical professionals, further complicating their access to effective treatment. Moreover, the stigma associated with addiction affects funding and policy decisions, as addiction treatment programs may not receive the necessary support or prioritization compared to other health issues. Addressing this challenge requires ongoing public education and advocacy efforts to shift societal attitudes and promote a more compassionate and supportive approach to addiction treatment. Reducing stigma is essential for improving treatment accessibility and encouraging more individuals to seek the help they need, ultimately enhancing market growth.

Market Segmentation Analysis

By Treatment Type

The UK Addiction Treatment Market encompasses various segments addressing different types of substance dependencies. Alcohol Addiction Treatment targets alcohol dependency through detoxification, counseling, and medication-assisted treatment (MAT), driven by the rising prevalence of alcohol abuse and its health complications. Tobacco/Nicotine Addiction Treatment focuses on individuals addicted to tobacco and nicotine, utilizing behavioral therapies, nicotine replacement therapies (NRTs), and medications like varenicline and bupropion, supported by public health campaigns and smoking cessation programs. Opioid Addiction Treatment is critical due to the ongoing opioid crisis, offering MAT with drugs such as methadone, buprenorphine, and naltrexone, along with counseling and support groups, driven by high rates of opioid dependency and fatalities. Other Substances Addiction Treatment addresses addictions to substances like cocaine, methamphetamines, and prescription medications, often involving customized treatment plans that combine behavioral therapy and medication.

By Drug Type

The UK Addiction Treatment Market features a range of key medications essential for treating various substance dependencies. Bupropion and Varenicline are primarily used for tobacco cessation, reducing cravings and withdrawal symptoms. Acamprosate helps stabilize chemical imbalances in the brain for alcohol addiction treatment, while Disulfiram deters alcohol consumption by causing adverse reactions when alcohol is ingested. Naltrexone is effective for both alcohol and opioid addiction, blocking the euphoric effects of these substances. Methadone and Buprenorphine are crucial for managing opioid addiction, reducing withdrawal symptoms and cravings, with Buprenorphine posing a lower risk of misuse. Nicotine Replacement Products like patches, gums, and lozenges aid in gradually reducing nicotine dependency. The market also includes emerging and off-label medications that show promise in addiction treatment.

Segments

Based on Treatment Type

Alcohol Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Opioid Addiction Treatment
Other Substances Addiction Treatment

Based on Drug Type

Bupropion
Varenicline
Acamprosate
Disulfiram
Naltrexone
Methadone
Buprenorphine
Nicotine Replacement Products
Other

Based on Treatment Center

Outpatient Treatment Centers
Residential Treatment Centers
Inpatient Treatment Centers

Based on Distribution Channel

Hospitals Pharmacies
Medical Stores
Others

Based on Region

London
Midlands
North West
Other Regions

Regional Analysis

London (25%):

London is the leading region in the UK Addiction Treatment Market, accounting for approximately 25% of the market share. As the capital city, London has a high population density and a diverse demographic profile, contributing to a higher prevalence of substance abuse disorders. The city’s extensive healthcare infrastructure, including numerous specialized addiction treatment centers and hospitals, supports this substantial market share. Furthermore, London benefits from significant governmental and non-governmental funding aimed at combating addiction, along with numerous public awareness campaigns and support programs. These factors collectively drive the high demand for addiction treatment services in the region.

Scotland (15%):

Scotland represents about 15% of the market share in the UK Addiction Treatment Market. The region faces significant challenges related to alcohol and drug abuse, with higher-than-average rates of substance abuse disorders. The Scottish government has prioritized addiction treatment through various health policies and funding programs aimed at reducing substance abuse and improving access to care. Scotland’s market share is supported by a network of treatment centers, both public and private, offering a range of services from inpatient care to community-based programs.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Teva Pharmaceutical Industries Ltd.
Pfizer, Inc.
Glenmark Pharmaceuticals
GSK plc
Johnson & Johnson Services, Inc.
Novartis AG
Perrigo Company plc.
Cipla
Reddy’s Laboratories Limited
Hikma Pharmaceuticals Plc.
Indivior Inc.
Mylan N.V.
Eli Lilly and Company

Competitive Analysis

The UK Addiction Treatment Market is highly competitive, with major players like Teva Pharmaceutical Industries Ltd., Pfizer, Inc., and GSK plc leading the industry. These companies have established strong market positions through extensive product portfolios and continuous innovation in addiction treatment therapies. Novartis AG and Johnson & Johnson Services, Inc. leverage their global presence and robust R&D capabilities to introduce advanced treatment options. Indivior Inc. and Mylan N.V. specialize in medication-assisted treatments, addressing opioid addiction with targeted solutions. Companies like Cipla, Glenmark Pharmaceuticals, and Dr. Reddy’s Laboratories Limited focus on cost-effective generic medications, enhancing market accessibility. Hikma Pharmaceuticals Plc. and Perrigo Company plc. contribute with a diverse range of pharmaceuticals, while Eli Lilly and Company invest in cutting-edge research to develop new therapies. This competitive landscape fosters innovation, driving market growth and improving patient outcomes.

Recent Developments

In June 2021, Terveystalo Healthcare acquired a 72% shareholding in Feelgood Svenska AB and announced a recommended mandatory offer of SEK 5.7 per share. This strategic acquisition aims to enhance Terveystalo’s service offerings and expand its market presence in the healthcare sector. The deal underscores Terveystalo’s commitment to providing comprehensive healthcare solutions and improving patient outcomes through strategic partnerships and acquisitions.

In June 2021, The Ridge opened a new office dedicated to offering specialized private treatment for individuals suffering from drug and alcohol addiction. This facility aims to provide exclusive, high-quality care, ensuring personalized treatment plans tailored to each patient’s needs. The new office signifies The Ridge’s continued expansion and commitment to addressing substance abuse issues with professional, compassionate care.

In On May 14, 2024, Lifespan Health System launched a new addiction treatment program called Addiction Care Today, offering same-day help. The program aims to provide immediate assistance with walk-in and same-day appointments for individuals seeking treatment for substance use disorders. This initiative reflects Lifespan Health System’s dedication to increasing accessibility and timeliness of care for those battling addiction, ensuring prompt and effective treatment options.

In On February 9, 2024, the Union Council of Ministers announced the launch of 41 addiction treatment facilities in Delhi for drug addicts. These centers will offer free treatment, counseling, and medications to individuals struggling with substance addiction. This initiative demonstrates the government’s commitment to addressing the addiction crisis by providing accessible, comprehensive support and resources to those in need.

In May 2023, Camurus AB, a Swedish biopharmaceutical company, announced that the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder (OUD). This approval marks a significant milestone for Camurus AB, enhancing their ability to provide innovative, long-acting treatment options for individuals suffering from OUD.

Market Concentration and Characteristics

The UK Addiction Treatment Market is characterized by a moderate level of market concentration, with several key players holding significant market shares. Companies such as Teva Pharmaceutical Industries Ltd., Pfizer, Inc., and GSK plc dominate the landscape, leveraging their extensive product portfolios and strong R&D capabilities. The market also features a mix of established pharmaceutical giants and specialized companies like Indivior Inc. and Camurus AB, which focus on innovative addiction treatment solutions. The competitive environment fosters continuous innovation and improvement in treatment methodologies, with a strong emphasis on personalized care and the integration of digital health technologies. This dynamic market is driven by increasing demand for effective addiction treatment services, government initiatives, and advancements in medical treatments and technologies.

Report Coverage

The research report offers an in-depth analysis based on Treatment Type, Drug Type, Treatment Center, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The integration of telemedicine and mobile health apps will continue to grow, providing more accessible and flexible treatment options for individuals across the UK.

Ongoing and increased government support and funding for addiction treatment programs will enhance the availability and quality of services, driving market growth.

Continued research and development will lead to more effective MAT options, improving recovery rates and reducing relapse among patients.

The trend towards personalized and holistic treatment plans will strengthen, offering tailored care that addresses the unique needs of each patient for better outcomes.

Greater emphasis on integrating mental health care with addiction treatment will emerge, recognizing the complex interplay between mental health disorders and substance abuse.

Outpatient treatment centers will become more prevalent, providing flexible, cost-effective care options that allow patients to maintain their daily responsibilities.

Emerging therapies, such as cognitive-behavioral therapy (CBT) and contingency management, will be increasingly adopted, enhancing the effectiveness of addiction treatment programs.

Continuous efforts to destigmatize addiction and raise awareness about available treatment options will encourage more individuals to seek help.

The establishment and expansion of private addiction treatment centers will offer additional high-quality treatment options, catering to a broader range of patients.

Efforts to improve the accessibility of addiction treatment services in rural and underserved areas will ensure that more individuals receive the care they need, regardless of location.

CHAPTER NO. 1 : INTRODUCTION 14

1.1.1. Report Description 14

Purpose of the Report 14

USP & Key Offerings 14

1.1.2. Key Benefits for Stakeholders 14

1.1.3. Target Audience 15

1.1.4. Report Scope 15

CHAPTER NO. 2 : EXECUTIVE SUMMARY 16

2.1. UK Addiction Treatment Market Snapshot 16

2.1.1. UK Addiction Treatment Market, 2018 – 2032 (USD Million) 17

CHAPTER NO. 3 : UK ADDICTION TREATMENT MARKET – INDUSTRY ANALYSIS 18

3.1. Introduction 18

3.2. Market Drivers 19

3.2.1. Driving Factor 1 Analysis 19

3.2.2. Driving Factor 2 Analysis 20

3.3. Market Restraints 21

3.3.1. Restraining Factor Analysis 21

3.4. Market Opportunities 22

3.4.1. Market Opportunity Analysis 22

3.5. Porter’s Five Forces Analysis 23

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 24

4.1. Company Market Share Analysis – 2023 24

4.1.1. UK Addiction Treatment Market: Company Market Share, by Volume, 2023 24

4.1.2. UK Addiction Treatment Market: Company Market Share, by Revenue, 2023 25

4.1.3. UK Addiction Treatment Market: Top 6 Company Market Share, by Revenue, 2023 25

4.1.4. UK Addiction Treatment Market: Top 3 Company Market Share, by Revenue, 2023 26

4.2. UK Addiction Treatment Market Company Revenue Market Share, 2023 27

4.3. Company Assessment Metrics, 2023 28

4.3.1. Stars 28

4.3.2. Emerging Leaders 28

4.3.3. Pervasive Players 28

4.3.4. Participants 28

4.4. Start-ups /SMEs Assessment Metrics, 2023 28

4.4.1. Progressive Companies 28

4.4.2. Responsive Companies 28

4.4.3. Dynamic Companies 28

4.4.4. Starting Blocks 28

4.5. Strategic Developments 29

4.5.1. Acquisitions & Mergers 29

New Product Launch 29

UK Expansion 29

4.6. Key Players Product Matrix 30

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 31

5.1. PESTEL 31

5.1.1. Political Factors 31

5.1.2. Economic Factors 31

5.1.3. Social Factors 31

5.1.4. Technological Factors 31

5.1.5. Environmental Factors 31

5.1.6. Legal Factors 31

5.2. Adjacent Market Analysis 31

CHAPTER NO. 6 : UK ADDICTION TREATMENT MARKET – BY TREATMENT TYPE SEGMENT ANALYSIS 32

6.1. UK Addiction Treatment Market Overview, by Treatment Type Segment 32

6.1.1. UK Addiction Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 33

6.1.2. UK Addiction Treatment Market Attractiveness Analysis, By Treatment Type 34

6.1.3. Incremental Revenue Growth Opportunity, by Treatment Type, 2024 – 2032 34

6.1.4. UK Addiction Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 35

6.2. Alcohol Addiction Treatment 36

6.3. Tobacco/Nicotine Addiction Treatment 37

6.4. Opioid Addiction Treatment 38

6.5. Other Substances Addiction Treatment 39

CHAPTER NO. 7 : UK ADDICTION TREATMENT MARKET – BY DRUG TYPE SEGMENT ANALYSIS 40

7.1. UK Addiction Treatment Market Overview, by Drug Type Segment 40

7.1.1. UK Addiction Treatment Market Revenue Share, By Drug Type, 2023 & 2032 41

7.1.2. UK Addiction Treatment Market Attractiveness Analysis, By Drug Type 42

7.1.3. Incremental Revenue Growth Opportunity, by Drug Type, 2024 – 2032 42

7.1.4. UK Addiction Treatment Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 43

7.2. Bupropion 44

7.3. Varenicline 45

7.4. Acamprosate 46

7.5. Disulfiram 47

7.6. Naltrexone 48

7.7. Methadone 48

7.8. Buprenorphine 49

7.9. Nicotine Replacement Products 49

7.10. Others 50

CHAPTER NO. 8 : UK ADDICTION TREATMENT MARKET – BY TREATMENT CENTER SEGMENT ANALYSIS 51

8.1. UK Addiction Treatment Market Overview, by Treatment Centre Segment 51

8.1.1. UK Addiction Treatment Market Revenue Share, By Treatment Center, 2023 & 2032 52

8.1.2. UK Addiction Treatment Market Attractiveness Analysis, By Treatment Center 53

8.1.3. Incremental Revenue Growth Opportunity, by Treatment Center, 2024 – 2032 53

8.1.4. UK Addiction Treatment Market Revenue, By Treatment Center, 2018, 2023, 2027 & 2032 54

8.2. Outpatient Treatment Centers 55

8.3. Residential Treatment Centers 56

8.4. Inpatient Treatment Centers 57

CHAPTER NO. 9 : UK ADDICTION TREATMENT MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 58

9.1. UK Addiction Treatment Market Overview, by Distribution Channel Segment 58

9.1.1. UK Addiction Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 59

9.1.2. UK Addiction Treatment Market Attractiveness Analysis, By Distribution Channel 60

9.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 60

9.1.4. UK Addiction Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 61

9.2. Hospitals Pharmacies 62

9.3. Medical Stores 63

9.4. Others 64

CHAPTER NO. 10 : COMPANY PROFILES 65

10.1. Teva Pharmaceutical Industries Ltd. 65

10.1.1. Company Overview 65

10.1.2. Product Portfolio 65

10.1.3. Swot Analysis 65

10.1.4. Business Strategy 66

10.1.5. Financial Overview 66

10.2. Pfizer, Inc. 67

10.3. Glenmark Pharmaceuticals 67

10.4. GSK plc 67

10.5. Johnson & Johnson Services, Inc. 67

10.6. Novartis AG 67

10.7. Perrigo Company plc. 67

10.8. Cipla 67

10.9. Dr. Reddy’s Laboratories Limited 67

10.10. Hikma Pharmaceuticals Plc. 67

10.11. Indivior Inc. 67

10.12. Mylan N.V. 67

10.13. Eli Lilly and Company 67

CHAPTER NO. 11 : RESEARCH METHODOLOGY 68

11.1. Research Methodology 68

11.1.1. Phase I – Secondary Research 69

11.1.2. Phase II – Data Modeling 69

Company Share Analysis Model 70

Revenue Based Modeling 70

11.1.3. Phase III – Primary Research 71

11.1.4. Research Limitations 72

Assumptions 72

List of Figures

FIG NO. 1. UK Addiction Treatment Market Revenue, 2018 – 2032 (USD Million) 18

FIG NO. 2. Porter’s Five Forces Analysis for UK Addiction Treatment Market 24

FIG NO. 3. Company Share Analysis, 2023 25

FIG NO. 4. Company Share Analysis, 2023 26

FIG NO. 5. Company Share Analysis, 2023 26

FIG NO. 6. Company Share Analysis, 2023 27

FIG NO. 7. UK Addiction Treatment Market – Company Revenue Market Share, 2023 28

FIG NO. 8. UK Addiction Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 34

FIG NO. 9. Market Attractiveness Analysis, By Treatment Type 35

FIG NO. 10. Incremental Revenue Growth Opportunity by Treatment Type, 2024 – 2032 35

FIG NO. 11. UK Addiction Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 36

FIG NO. 12. UK Addiction Treatment Market for Alcohol Addiction Treatment, Revenue (USD Million) 2018 – 2032 37

FIG NO. 13. UK Addiction Treatment Market for Tobacco/Nicotine Addiction Treatment, Revenue (USD Million) 2018 – 2032 38

FIG NO. 14. UK Addiction Treatment Market for Opioid Addiction Treatment, Revenue (USD Million) 2018 – 2032 39

FIG NO. 15. UK Addiction Treatment Market for Other Substances Addiction Treatment, Revenue (USD Million) 2018 – 2032 40

FIG NO. 16. UK Addiction Treatment Market Revenue Share, By Drug Type, 2023 & 2032 42

FIG NO. 17. Market Attractiveness Analysis, By Drug Type 43

FIG NO. 18. Incremental Revenue Growth Opportunity by Drug Type, 2024 – 2032 43

FIG NO. 19. UK Addiction Treatment Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 44

FIG NO. 20. UK Addiction Treatment Market for Bupropion, Revenue (USD Million) 2018 – 2032 45

FIG NO. 21. UK Addiction Treatment Market for Varenicline, Revenue (USD Million) 2018 – 2032 46

FIG NO. 22. UK Addiction Treatment Market for Acamprosate, Revenue (USD Million) 2018 – 2032 47

FIG NO. 23. UK Addiction Treatment Market for Disulfiram, Revenue (USD Million) 2018 – 2032 48

FIG NO. 24. UK Addiction Treatment Market for Naltrexone, Revenue (USD Million) 2018 – 2032 49

FIG NO. 25. UK Addiction Treatment Market for Methadone, Revenue (USD Million) 2018 – 2032 49

FIG NO. 26. UK Addiction Treatment Market for Buprenorphine, Revenue (USD Million) 2018 – 2032 50

FIG NO. 27. UK Addiction Treatment Market for Nicotine Replacement Products, Revenue (USD Million) 2018 – 2032 50

FIG NO. 28. UK Addiction Treatment Market for Others, Revenue (USD Million) 2018 – 2032 51

FIG NO. 29. UK Addiction Treatment Market Revenue Share, By Treatment Center, 2023 & 2032 53

FIG NO. 30. Market Attractiveness Analysis, By Treatment Center 54

FIG NO. 31. Incremental Revenue Growth Opportunity by Treatment Center, 2024 – 2032 54

FIG NO. 32. UK Addiction Treatment Market Revenue, By Treatment Center, 2018, 2023, 2027 & 2032 55

FIG NO. 33. UK Addiction Treatment Market for Outpatient Treatment Centers, Revenue (USD Million) 2018 – 2032 56

FIG NO. 34. UK Addiction Treatment Market for Residential Treatment Centers, Revenue (USD Million) 2018 – 2032 57

FIG NO. 35. UK Addiction Treatment Market for Inpatient Treatment Centers, Revenue (USD Million) 2018 – 2032 58

FIG NO. 36. UK Addiction Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 60

FIG NO. 37. Market Attractiveness Analysis, By Distribution Channel 61

FIG NO. 38. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 61

FIG NO. 39. UK Addiction Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 62

FIG NO. 40. UK Addiction Treatment Market for Hospitals Pharmacies, Revenue (USD Million) 2018 – 2032 63

FIG NO. 41. UK Addiction Treatment Market for Medical Stores, Revenue (USD Million) 2018 – 2032 64

FIG NO. 42. UK Addiction Treatment Market for Others, Revenue (USD Million) 2018 – 2032 65

FIG NO. 43. Research Methodology – Detailed View 69

FIG NO. 44. Research Methodology 70

List of Tables

TABLE NO. 1. : UK Addiction Treatment Market: Snapshot 17

TABLE NO. 2. : Drivers for the UK Addiction Treatment Market: Impact Analysis 20

TABLE NO. 3. : Restraints for the UK Addiction Treatment Market: Impact Analysis 22

Frequently Asked Questions:

What is the projected growth of the UK Addiction Treatment Market?

The UK Addiction Treatment Market is expected to grow from USD 433.69 million in 2023 to an estimated USD 774.40 million by 2032, with a CAGR of 6.48% from 2024 to 2032.

What are the key drivers of the UK Addiction Treatment Market?

Key drivers include the rising incidence of addiction cases, government initiatives to combat substance abuse, and advancements in treatment methodologies.

Which regions dominate the UK Addiction Treatment Market?

Major regions such as London, the Midlands, and the North West dominate the market due to their higher concentration of treatment facilities and healthcare infrastructure.

Who are the leading players in the UK Addiction Treatment Market?

Leading players include The Priory Group, Turning Point, and Forward Trust, known for their extensive service offerings and continuous innovation.

How are digital health technologies impacting the UK Addiction Treatment Market?

The integration of digital health technologies like telemedicine and mobile health apps is enhancing the accessibility and effectiveness of addiction treatment services across the UK.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –